Sensex, Nifty Decline For Second Straight Day; IT, Pharma Shares Drag
Domestic equity benchmarks S&P BSE Sensex and NSE Nifty 50 fell for the second straight session on Tuesday dragged by selling pressure in IT and pharma shares. For most part of the day, the benchmarks traded firm, with the Sensex climbing up as much as 1.35 per cent - or 414.11 points - to touch 31,086.70, after starting the session up 191.68 points at 30,864.27. The broader NSE Nifty 50 benchmark rose to as high as 9,161.65, having opened higher at 9,099.75 compared to its previous close of 9,039.25.
The Sensex ended 63 points or 0.21 per cent lower at 30,609.30 and the Nifty slipped 10 points to close at 9,029.05.
Eight of 11 sector gauges compiled by the National Stock Exchange ended higher, led by the Nifty Metal index, which gained 2.7 per cent. The auto and banking sector gauges rose 1.51 per cent and 0.9 per cent each respectively.
On the other hand, the Nifty IT index was the top loser, down 1.9 per cent.
Mid- and small-cap shares outperformed their larger peers, as the Nifty Midcap 100 index rose 1.3 per cent while the Nifty Smallcap 100 index advanced 0.8 per cent.
Bharti Airtel was the top Nifty loser, dropping 6 per cent to close at Rs 558 on the BSE, after news agency Bloomberg reported that its parent, Bharti Telecom, was looking at raising $1 billion by selling shares in the mobile phone operator through a block deal.
Bajaj Finserv, TCS, Bajaj Finance, Sun Pharma, Hero MotoCorp, Cipla, Infosys, Tech Mahindra, Vedanta and UPL were also among the losers.
On the flip side, JSW Steel, Eicher Motors, Titan, UltraTech Cement, IndusInd Bank, Shree Cements, Hindalco and Nestle were among the gainers.
The overall market breadth was neutral as 1,225 closed higher while 1,125 ended lower on the BSE.
Equities elsewhere in Asia climbed higher, with MSCI's broadest index of Asia-Pacific shares outside Japan rising 1.6 per cent, as investors looked past US-China trade tensions, and focused on more stimulus in China and a gradual reopening of the world economy.
-
High US Salaries, No Green Card Certainty: The Financial Calculation Facing Indian H-1B Families
The suspension of PERM processing at eight technology employers does not cancel existing H-1B visas. What it does is force a question many Indian families have been avoiding: is the US salary worth tying your career and family plans to one employer?
-
Unhedged Position: Can India See An Indonesia-Style Time Correction?
The Nifty is trading below levels it first clocked in 2024. Is there, then, as I have suggested in the headline, potential that the current time correction drags on painfully for the next three-five, even ten years?
-
Navigating Friction And Energy Realities: An Analysis Of Marco Rubio's October Visit To India
Occurring at a critical juncture marked by stalled trade negotiations and escalating geopolitical pressures over global energy supplies, the visit offers a profound window into modern US-India relations.
-
India Exports Capital. Why Not Export Trusteeship?
The big question, then, is whether India can build an institution that global borrowers, investors, banks, and lawyers can trust, even without an Indian connection.
-
France's Economy & Politics Are In Crisis | The Reason Why
Let's look at how the French economy and politics evolved under Nicolas Sarkozy, Franois Hollande and Emmanuel Macron.
-
You May Inherit The Business. You Must Earn Its Credibility.
Succession tests the founder's ability to share authority as much as it tests the next generation's readiness to assume it.
-
Signing Deals Is One Thing; Making Them Work Is Another | The Week In Whys
Sometimes, things don't turn out as planned. Indian companies have lost some bids to rivals, some projects won't produce until 2030.
-
FOMC Wall, PERM Suspension, Hospital Stocks | Talking Points This Week
A PERM suspension would directly affect green-card sponsorship rather than H-1B visas, so the near-term earnings impact could remain relatively limited. The key question is whether this marks a new phase in US scrutiny of Indian IT.
-
Everything, Everywhere, All At Once: Dalal Street's Week To Forget | Joining The Dots
Visa curbs, a Starlink spat and cancer drug caps: what connects this week's shocks for Indian markets
-
India Is Going Abroad For Critical Minerals. But It May Take Years To Pay Off | The Reason Why
Although India's steps are in the right direction, they remain modest compared with India's growing dependence.